Tobacco.org

• CABE: Going up without the smoke 

Need a nicotine hit? Want to beat the smoking ban? A smokeless cigarette could be the answer, for the long - or short - haul. Just be prepared for some funny looks, writes ROSEMARY Mac CABE . . .

Ryanair now sells the other most popular type, in the form of Similar smokeless cigarettes.

Ryanair's head of communications, Stephen McNamara, says the product was introduced due to customer demand. "Some passengers can find it stressful to spend long journeys without a cigarette so we introduced the product based on customer feedback and to cater to passenger demand. It seemed a logical step to introduce a product that could provide smokers with relief from nicotine withdrawal. . . .

I spent a day with Ryanair's Similar branded smokeless cigarettes: a packet of 10, purchased for €6 on board a Ryanair flight, to see how it feels to smoke on the right side of the law.

The first thing I notice is that they smell, to all intents and purposes, like what one's mother might call "sucky sweets" - irrefutably better than mainstream cigarettes, albeit slightly strange. They feel like real cigarettes and, crucially, they look like them. . . .

Smoking a cigarette that looks like a cigarette, acts like a cigarette but neither tastes nor feels like a cigarette (while giving you more nicotine than a cigarette) seems an odd choice.

Jump to full article »

• Physicians Urge FDA to Justify Condemnation of E-Cigarettes 

"We urge FDA to make public the laboratory data behind the July 22 condemnation of electronic cigarettes, along with comparable data on pharmaceutical nicotine products and conventional cigarettes. Then, on the basis of these data, either fully justify or retract the July 22 condemnation of electronic cigarettes," says Joel L. Nitzkin, Chair of the American Association of Public Health Physicians Tobacco Control Task Force in a letter to the FDA.

The letter specifically targets the new tobacco legislation that passed through Congress this summer which gives the FDA power to regulate tobacco products in the United States and notes that the success rate of current smokers who attempt to quit by using pharmaceutical aids is as low as 5%. Making smokers more aware of less harmful alternatives, snus and e-cigarettes included, could significantly reduce the amount of smokers who die due to tobacco-related illnesses.

"Contrary to prevailing conventional wisdom, virtually all the heart and lung disease from conventional cigarettes, and an estimated 98% of the cancer mortality, are due to direct inhalation of fresh products of combustion deep into the lung. Our best estimate (based on the work of Pankow et al and others) is that only about 2% of the cancer mortality from cigarettes is from the named carcinogens commonly found in tobacco products," says the letter. The FDA's study in July found miniscule amounts of carcinogens in a few e-cigarette cartridges, but failed to provide any data on the amount of those same carcinogens in pharmaceutical nicotine products.

Jump to full article »

• Will Cigarette Maker Reynolds Try Kicking the Habit?  

It would be either one of the most cynical diversifications ever--or a brilliant stroke of synergy.

If a report in The Wall Street Journal is correct, America's second-largest seller of cigarettes may soon be peddling products that help people quit smoking. The Journal reported on Nov. 9 that Reynolds American (RAI), the distributor of Pall Mall, Camel, and Natural American Spirit cigarette brands as well as smokeless tobacco, is in "advanced talks" with Niconovum, a Swedish manufacturer of nicotine replacement products such as gum and mouth spray. University of Ottawa law professor David Sweanor told the Journal he was briefed by people close to the deal.

The move would mark the first time that a big tobacco company also sold smoking-cessation products, according to industry analysts. But it would be in line with the industry's efforts to diversify as cigarette purchases shrink in the U.S. One analyst referred to a purchase of Niconovum as a "cheap hedge" against the smoking decline. . . .

But as Morningstar's Gorham points out, Reynolds can make far more money convincing people to smoke than helping them quit. The cost per unit to produce cigarettes is extremely low—operating margins average 25%-30% industrywide, he says, which is high for consumer goods. (Pepsi (PEP), by comparison, which enjoys enormous scale and volume operating margins, reaches into the high teens, according to Gorham.)

It's unlikely that returns from smoking-cessation products can compete with that anytime soon. "I think we're talking 20 years-plus at this point before tobacco sales are offset by other sources," says Gorham.

Indeed, some view any talks between Reynolds and Niconovum as more of a publicity stunt, designed to place Reynolds in a better light.

Jump to full article »

• E-Cigarettes Under Fire  

As more cities ban smoking in restaurants and bars, there is a newer product to the United States that makers claim you can still smoke indoors. It's under fire from cities across the country, the Food and Drug Administration and a metro parent.

If you've been to the mall lately, you may have seen a kiosk selling electronic cigarettes. We've found the kiosks at Independence Center and Oak Park mall.

If you walk past the kiosk at Oak Park, a salesperson will ask if you smoke.

At Smoke51 we were shown a product that closely resembled a real cigarette. It comes with a battery and filter and even comes in flavors.

"There's a heating element that steams water, nicotine, and flavor so you're going to see me blow out smoke but it's actually steam or water vapor," the salesman said.

There are many questions about how this product is marketed.

Jump to full article »

• E Cigarettes May Be More Effective Than Swine Flu Vaccine  

According to the Centers for Disease Control, during 2000-2004, "An estimated 443,000 persons in the United States died prematurely each year from smoking or exposure to secondhand smoke. During 2001-2004, the average annual smoking-attributable health-care expenditures nationwide were approximately $96 billion. When combined with productivity losses of $97 billion, the total economic burden of smoking is approximately $193 billion per year."

Comparing the health risks of tobacco smoking to the Swine Flu brings out some interesting and thought provoking statistics. According to President Obama's Council of Advisors on Science and Technology on H1N1, "A plausible scenario is that the epidemic could cause between 30,000 and 90,000 deaths in the United States." That puts the comparison of real deaths of 443,000 smokers to a "war games guess" of 30,000 to 90,000 for the H1N1 influenza for which the government recently declared a Health Emergency. That declaration and the shortage of the H1N1 vaccine has caused a panic in the U.S.

No study or statistic has been offered that points to the Swine Flu as being more deadly than tobacco cigarettes in causing death, yet a disproportional effort in preventative measures are currently being channeled to defend against a lower risk health issue. Toxic tobacco smoke contains many additional chemicals, including carbon monoxide and tar which is a sticky substance that accumulates in the lungs, causing lung cancer and respiratory distress. Tobacco is the leading cause of preventable death in the world and is responsible for more than 5 million deaths each year.

What the flu vaccine is to H1N1 as a preventative, the electronic cigarette may be for the tobacco smoker. An electronic cigarette is a futuristic advancement in science

Jump to full article »

• New Study Reveals Quitting Smoking is Good but Switching to Low-risk Nicotine Products is Usually Better 

Prof. Carl V. Phillips, just published in Harm Reduction Journal, shows that for most smokers, immediately switching to a low-risk alternative will lower their risk of dying from their habit more than quitting eventually, even if they use the smoke-free product for the rest of their lives. . . .

Professor Phillips is an epidemiologist and health policy researcher, journal editor, popular educator, and consultant. He and his work group are leading advocates of tobacco harm reduction, and he advises and works with many other organizations who are trying to promote it, some of which are companies that hope to profit from selling low-risk nicotine products. The www.TobaccoHarmReduction.org research group at the University of Alberta School of Public Health is partially supported by an unrestricted (completely hands-off) grant from U.S. Smokeless Tobacco Company. No funder, company, or other organization played any role in initiating, designing, or conducting this research.

Jump to full article »

• Vaporized Propylene Glycol, a Key Ingredient in Electronic Cigarettes, May Prevent Pneumonia, Influenza, and Other Respiratory Diseases 

The ingredients in most electronic cigarette cartridges manufactured today include propylene glycol, nicotine, and a flavoring. The 1942 study by Dr. Oswald Hope Robertson of the University of Chicago's Billings Hospital showed that Propylene glycol, the most prevalent ingredient in electronic cigarette cartridges, was found to possibly prevent pneumonia, influenza, and other respiratory diseases when vaporized and inhaled.

Additional studies in monkeys and other animals were undertaken to determine long-term effects, especially the potential for accumulation in the lungs. After a few months of treatment, no ill effects were discovered.

Smokers can enjoy all the engrained habits of smoking; hand-to-mouth, throat hit, visual smoke, nicotine delivery, with none of the negative effects of inhaling the dangerous smoke

Now the electronic cigarette may not only help individuals to reduce and quit smoking regular cigarettes, but it also may help to prevent some of the respiratory diseases caused by the harmful "cancer sticks". Additionally with the pandemic H1N1 influenza virus expected to cause a record number of deaths this season there is no better time for smokers to cut back or quit with the aid of the electronic cigarette.

Jump to full article »

• Cancer institute studies smokeless tobacco 

Is using smokeless tobacco just as harmful as smoking, or is it potentially a safer option?

Getting a definitive answer to that question has proved elusive despite centuries of medical research.

Resolving the issue, and providing clarity amid the heated rhetoric, has prompted a new series of medical studies sponsored by the National Cancer Institute.

One set focuses on whether such smokeless products as snus and the dissolvable products from R.J. Reynolds Tobacco Co., provide "a truly less-harmful alternative to conventional tobacco products, both at the individual and population level," according to the institute's grant application.

Another set, including one that was started Sept. 1 at Wake Forest University School of Medicine, is aimed at developing strategy to encourage reduced use or even quitting smokeless-tobacco products. Wake Forest is receiving a $2.9 million grant for its study.

Maura Payne, a spokeswoman for Reynolds, said that the company supports "well-designed studies" that could help develop science-based, tobacco-harm-reduction strategies." Payne said that Reynolds does not promote its new smokeless products as a way to quit smoking.

The institute said that the studies are necessary because "previous tobacco-use reduction efforts pursued by the public-health community were disadvantaged by incomplete knowledge and methods for evaluating the health impact of modified tobacco products."

Jump to full article »

• Designing A Safer Cigarette 

What if we had a less dangerous cigarette for people who can't kick the habit, letting them keep on smoking but stay alive longer while they're doing it? It's available in Canada, France, Russia and a few places in Asia. The 350 million smokers in China may also get their hands on it. The U.S.? Forget it.

It's another perverse result of the 1998 settlement that had tobacco companies--and, ultimately, their customers--chipping in to balance state budgets and pay for lawyers' yachts. The deal turned the big tobacco companies into a cartel and locked in their market shares. The state attorneys general who put together the $206 billion agreement ward off potential competitors so the money keeps flowing to their states. One way to fend off rivals: pounce on any company making health claims. How convenient for Philip Morris and R.J. Reynolds.

In this case the target is an eight-year-old Hong Kong biotech company, Filligent. Its MicroBlue filter blocks many of the toxins that make a cigarette dangerous but doesn't disturb the ingredients that give it flavor and produce that seductive though addictive nicotine buzz. "For years the public health community has just assumed that the smoke from cigarettes is all bad," says Scott Ballin, director for the Alliance for Health, Economic & Agriculture Development in Washington, D.C., which is funded by economic development groups in tobacco-growing states and has been critical of the settlement. "Now advances in basic science have given us a much more nuanced understanding of what's in that stuff--what's harmful and what's mainly benign."

Fewer than 5% of the people who try to stop smoking succeed for as long as five years, says Filligent Chief Executive Melissa Mowbray-d'Arbela. So given the futility of getting smokers to end their addiction, tobacco experts such as Dr. Judith Mackay of the World Lung Foundation in New York say Filligent's product could be the next best thing to quitting.

Jump to full article »

• Firestorm over smokeless cigarette  

Electronic cigarettes are opening a new front in the tobacco wars as state and local lawmakers try to restrict the product, which may allow users to circumvent smoking bans.

The battery-powered device is made up of a cartridge containing nicotine, flavoring and chemicals. It turns nicotine, which is addictive, into a vapor that is inhaled. Users say they're "vaping," not smoking.

E-cigarettes are used by at least a half-million Americans, says Matt Salmon, head of the Electronic Cigarette Association.

"People who smoke ought to have better alternatives, because some can't quit," he says. His father, a longtime smoker, died last week of cancer and emphysema.

Public health officials question the safety of e-cigarettes. The Food and Drug Administration, which regulates tobacco and nicotine replacement devices, says the e-cigarettes it tested had carcinogens. E-cigarette distributors have filed a lawsuit challenging the FDA's authority.

"It's a new frontier. We don't know what the dangers are," says John Banzhaf of Action on Smoking and Health, an anti-smoking group.

"We're actively investigating these companies and their products," says Connecticut Attorney General Richard Blumenthal. Other actions:

Jump to full article »

• Use An E-Cigarette, Reduce Risk of Heart Disease 

E-CigaretteDirect.com recommends that smokers switch to electronic cigarettes to protect themselves and their loved ones from secondhand smoke and heart disease. You don't have to be a smoker for smoke to harm you. Secondhand smoke is known to be even more dangerous than first hand smoke.

The recent study titled Secondhand Smoke Exposure and Cardiovascular Effects assess the relationship among second hand smoke and acute coronary events. The scientists found that smoking regular cigarettes increases the risk of heart disease by 25-30%. The Surgeon General agrees with this conclusion in his 2006 report.

To avoid second hand smoke for others, smokers have a few options: Quit, leave the premises to smoke, or try an electronic cigarette. "The e-cigarette produces ZERO second hand smoke. None. The 'smoke' that is expelled is actually water vapor", states Gina King of E-CigaretteDirect. "People can use this smoking alternative to decrease the risk of smoking for them and their loved ones. This study only proves that regular cigarettes are dangerous for more people than just the smoker".

Jump to full article »

• Patents - Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First 'Modified Risk' Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee ($$) 

Star Scientific, Inc. (NASDAQ:STSI) makers of low-nitrosamine smokeless tobacco products, announced that the company will utilize a novel, patented method for cultivation, curing and preparation of tobacco to formulate dissolvable smokeless tobacco products. This new curing process was the subject of a patent application filed in December, 2008. Its use has resulted in tobacco leaf with significantly lower levels of tobacco-specific nitrosamines (TSNAs) than previously achieved using the StarCured curing process: the International Agency for Research on Cancer previously has reported on the low levels of nitrosamines in Star's products. The company believes that this novel process, as...

Jump to full article »

• Lady Victoria Hervey is puffing them but is the 'no-cancer' cigarette really a healthy option?  

Sarah Harding has been spotted puffing away on one and Kate Moss is said to be on the waiting list for the most unlikely must-have accessory of London Fashion Week: an electronic cigarette.

Perhaps even more surprising is the woman who is touting these little white sticks around town: Lady Victoria Hervey.

The 32-year-old former It girl has just returned from Los Angeles, where she had been pursuing an acting career, as the face of SmokeStik Royale, a luxury electronic cigarette, which she has helped to design. . . .

'I was even able to smoke this on the plane,' says Lady Victoria, 'and the crew were all asking for a drag.'

The SmokeStik Royale is pearlised, emblazoned with the Hervey family crest - a crown and snow leopard - and has a bejewelled tip.

Despite the camp styling, there is a serious side to Victoria's mission. Her father Victor, the sixth Marquis of Bristol, died in 1985, aged 69, from the chronic lung disease emphysema, the result of a lifelong tobacco addiction.

Jump to full article »

• Star Scientific plans to seek FDA approval for new products 

Star Scientific Inc. wants to be the first company seeking approval from federal regulators to sell so-called "modified-risk" tobacco products with reduced toxins.

The Petersburg-based company, which makes smokeless tobacco products, said yesterday that it plans to ask the Food and Drug Administration next year for approval to market its products as potentially less risky to consumers' health.

Congress passed legislation this year that for the first time gives the FDA authority to regulate tobacco products. The legislation also lets tobacco companies submit products for scientific review by the FDA and approval to be marketed as "modified-risk."

Star did not provide details about any new products, which it said are still in development. Company spokeswoman Sara Machir said one would be similar to the dissolvable, lozenge-like smokeless tobacco products the company now sells under brand names Stonewall and Ariva.

"What would distinguish it is the even significantly lower nitrosamine levels," she said.

Jump to full article »

• Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First 'Modified Risk' Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee 

Star Scientific, Inc. (NASDAQ: STSI) makers of low-nitrosamine smokeless tobacco products, announced today that the company will utilize a novel, patented method for cultivation, curing and preparation of tobacco to formulate dissolvable smokeless tobacco products. This new curing process was the subject of a patent application filed in December, 2008. Its use has resulted in tobacco leaf with significantly lower levels of tobacco-specific nitrosamines (TSNAs) than previously achieved using the StarCured(R) curing process: the International Agency for Research on Cancer previously has reported on the low levels of nitrosamines in Star's products. The company believes that this novel process, as reflected in its patent application, will enable the company to achieve the lowest toxin levels anywhere in the world. Star plans to submit the products to the FDA for approval to market as "modified risk" tobacco products, under Section 911 of the new Family Smoking Prevention and Tobacco Control Act, once formulation and testing of the new product is completed in early 2010.

Jump to full article »